These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10209206)

  • 61. Interaction of fusion peptides from HIV gp41 with membranes: a time-resolved membrane binding, lipid mixing, and structural study.
    Buzón V; Padrós E; Cladera J
    Biochemistry; 2005 Oct; 44(40):13354-64. PubMed ID: 16201760
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.
    Eckert DM; Kim PS
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11187-92. PubMed ID: 11572974
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A molecular model for membrane fusion based on solution studies of an amphiphilic peptide from HIV gp41.
    Fujii G; Horvath S; Woodward S; Eiserling F; Eisenberg D
    Protein Sci; 1992 Nov; 1(11):1454-64. PubMed ID: 1303764
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein.
    Lu M; Kim PS
    J Biomol Struct Dyn; 1997 Dec; 15(3):465-71. PubMed ID: 9439994
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Conformational transitions of membrane-bound HIV-1 fusion peptide.
    Sáez-Cirión A; Nieva JL
    Biochim Biophys Acta; 2002 Aug; 1564(1):57-65. PubMed ID: 12100996
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Membrane structure of the human immunodeficiency virus gp41 fusion peptide by molecular dynamics simulation. II. The glycine mutants.
    Wong TC
    Biochim Biophys Acta; 2003 Jan; 1609(1):45-54. PubMed ID: 12507757
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of amino acid replacements, additions and deletions on the antiviral activity of a peptide derived from the HIV-1 GP41 sequence.
    Jiang S; Lin K
    Pept Res; 1995; 8(6):345-8. PubMed ID: 8838418
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution.
    Pereira FB; Goñi FM; Nieva JL
    FEBS Lett; 1995 Apr; 362(2):243-6. PubMed ID: 7720880
    [TBL] [Abstract][Full Text] [Related]  

  • 69. HIV gp41 fusion peptide increases membrane ordering in a cholesterol-dependent fashion.
    Lai AL; Freed JH
    Biophys J; 2014 Jan; 106(1):172-81. PubMed ID: 24411249
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A GxxxG-like motif within HIV-1 fusion peptide is critical to its immunosuppressant activity, structure, and interaction with the transmembrane domain of the T-cell receptor.
    Faingold O; Cohen T; Shai Y
    J Biol Chem; 2012 Sep; 287(40):33503-11. PubMed ID: 22872636
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Determination of the equilibrium micelle-inserting position of the fusion peptide of gp41 of human immunodeficiency virus type 1 at amino acid resolution by exchange broadening of amide proton resonances.
    Chang DK; Cheng SF
    J Biomol NMR; 1998 Nov; 12(4):549-52. PubMed ID: 9862130
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of HIV-1 envelope glycoprotein-mediated cell fusion by a DL-amino acid-containing fusion peptide: possible recognition of the fusion complex.
    Gerber D; Pritsker M; Gunther-Ausborn S; Johnson B; Blumenthal R; Shai Y
    J Biol Chem; 2004 Nov; 279(46):48224-30. PubMed ID: 15339935
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interbilayer lipid mixing induced by the human immunodeficiency virus type-1 fusion peptide on large unilamellar vesicles: the nature of the nonlamellar intermediates.
    Pereira FB; Valpuesta JM; Basañez G; Goñi FM; Nieva JL
    Chem Phys Lipids; 1999 Dec; 103(1-2):11-20. PubMed ID: 10701076
    [TBL] [Abstract][Full Text] [Related]  

  • 74. All-atom models of the membrane-spanning domain of HIV-1 gp41 from metadynamics.
    Gangupomu VK; Abrams CF
    Biophys J; 2010 Nov; 99(10):3438-44. PubMed ID: 21081093
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interaction of a basic amphipathic peptide from the carboxyterminal part of the HIV envelope protein gp41 with negatively charged lipid surfaces.
    Trommeshauser D; Galla HJ
    Chem Phys Lipids; 1998 Jul; 94(1):81-96. PubMed ID: 9721631
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Unexpected similarity between the carboxyl termini of lentivirus and pestivirus envelope glycoproteins.
    Garry RF
    AIDS; 2003 Jan; 17(2):276-7. PubMed ID: 12545096
    [No Abstract]   [Full Text] [Related]  

  • 77. Comparative evaluation of different methods for disulfide bond formation in synthesis of the HIV-2 antigenic determinant.
    Kudryavtseva EV; Sidorova MV; Ovchinnikov MV; Bespalova ZD; Bushuev VN
    J Pept Res; 1997 Jan; 49(1):52-8. PubMed ID: 9128100
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of the HIV-1 fusion peptide on the mechanical properties and leaflet coupling of lipid bilayers.
    Shchelokovskyy P; Tristram-Nagle S; Dimova R
    New J Phys; 2011 Feb; 13():25004. PubMed ID: 23505334
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular Dynamics Investigation of Lipid-Specific Interactions with a Fusion Peptide.
    Heller WT
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540705
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.